All enrolled sufferers who acquired not less than just one dose of zosuquidar or placebo during induction were monitored for the incidence of adverse gatherings (439 sufferers, 219 on zosuquidar and 210 on placebo). The commonest adverse gatherings ended up connected with the period of prolonged and substantial myelosuppression as https://lemmyi554uep7.iamthewiki.com/user